Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.

OBJECTIVE: Patients with acromegaly are at increased risk of developing colorectal carcinoma and premalignant tubulovillous adenoma. The pathogenesis of these neoplasms could involve a stimulatory effect of serum growth factors on colonic epithelial cell proliferation. The aim of this study was to e...

Full description

Bibliographic Details
Main Authors: Miraki-Moud, F, Jenkins, P, Fairclough, P, Jordan, S, Bustin, SA, Jones, A, Lowe, D, Monson, J, Grossman, AB, Besser, G, Camacho-Hübner, C
Format: Journal article
Language:English
Published: 2001
_version_ 1797053626344013824
author Miraki-Moud, F
Jenkins, P
Fairclough, P
Jordan, S
Bustin, SA
Jones, A
Lowe, D
Monson, J
Grossman, AB
Besser, G
Camacho-Hübner, C
author_facet Miraki-Moud, F
Jenkins, P
Fairclough, P
Jordan, S
Bustin, SA
Jones, A
Lowe, D
Monson, J
Grossman, AB
Besser, G
Camacho-Hübner, C
author_sort Miraki-Moud, F
collection OXFORD
description OBJECTIVE: Patients with acromegaly are at increased risk of developing colorectal carcinoma and premalignant tubulovillous adenoma. The pathogenesis of these neoplasms could involve a stimulatory effect of serum growth factors on colonic epithelial cell proliferation. The aim of this study was to evaluate changes in (1) serum IGF-I, IGF-II, IGFBP-3 and IGFBP-2 and (2) changes in local expression of IGFBPs and p53 in colonic epithelium in patients with colonic neoplasia with and without acromegaly. DESIGN: A cross-sectional retrospective study was performed. Fasting serum samples were obtained at the time of colonoscopy for patients with acromegaly and at the time of surgery for patients with colonic neoplasia without acromegaly. MEASUREMENTS: Serum IGF-I, IGF-II, IGFBP-2 and IGFBP-3 were measured using specific immunoassays. Tissue expression of IGFBP-2, IGFBP-3 and p53 status were determined by immunohistochemistry. PATIENTS: Group 1: 26 age- and sex-matched control subjects (range 40-69 years); group 2: 18 patients with acromegaly without colonic neoplasia (range 39-68 years); group 3: 18 patients with acromegaly and colonic neoplasia (range 41-74 years, 11 = adenoma, seven = carcinoma); group 4: 19 patients with colonic neoplasia without endocrine disease (range 43-91 years, four = adenoma, 15 = carcinoma). Immunohistochemical staining of colonic biopsies was performed for IGFBP-2, IGFBP-3 and p53 in groups 3 and 4. RESULTS: Mean serum IGF-I and IGFBP-3 levels were significantly elevated in group 2 (371 +/- 131 microg/l and 6.5 +/- 1.8 mg/l, respectively) and group 3 (379 +/- 174 microg/l and 5.8 +/- 1.6 mg/l, respectively), and significantly reduced in group 4 (103 +/- 36 microg/l and 2.4 +/- 1 mg/l) compared to controls (165 +/- 40 microg/l and 4.7 +/- 1 mg/l; P < 0.0001, P < 0.001, respectively). However, median serum IGFBP-2 levels were significantly elevated in group 3 (P < 0.01) and group 4 (P < 0.0001). Immunostaining for IGFBP-2 showed strong areas of immunoreactivity in the cytoplasm of malignant colonic epithelium compared to benign epithelium. IGFBP-3 immunostaining showed strong areas of immunoreactivity in the cytoplasm and in the nucleus of malignant and benign colonic epithelium compared to the normal epithelium. Nuclear staining for p53 was observed in three patients from group 3 (two carcinoma, one adenoma) and four patients from group 4 (all carcinoma). CONCLUSION: Our results describe changes in IGFBP-2 expression in colonic neoplasia in patients with and without acromegaly, which suggest that this binding protein may regulate local bioavailability of IGF, which in turn could modulate colonic cell proliferation and/or differentiation.
first_indexed 2024-03-06T18:46:18Z
format Journal article
id oxford-uuid:0ea46cc9-7339-479c-a03f-2ae93434bbfe
institution University of Oxford
language English
last_indexed 2024-03-06T18:46:18Z
publishDate 2001
record_format dspace
spelling oxford-uuid:0ea46cc9-7339-479c-a03f-2ae93434bbfe2022-03-26T09:47:00ZIncreased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0ea46cc9-7339-479c-a03f-2ae93434bbfeEnglishSymplectic Elements at Oxford2001Miraki-Moud, FJenkins, PFairclough, PJordan, SBustin, SAJones, ALowe, DMonson, JGrossman, ABBesser, GCamacho-Hübner, COBJECTIVE: Patients with acromegaly are at increased risk of developing colorectal carcinoma and premalignant tubulovillous adenoma. The pathogenesis of these neoplasms could involve a stimulatory effect of serum growth factors on colonic epithelial cell proliferation. The aim of this study was to evaluate changes in (1) serum IGF-I, IGF-II, IGFBP-3 and IGFBP-2 and (2) changes in local expression of IGFBPs and p53 in colonic epithelium in patients with colonic neoplasia with and without acromegaly. DESIGN: A cross-sectional retrospective study was performed. Fasting serum samples were obtained at the time of colonoscopy for patients with acromegaly and at the time of surgery for patients with colonic neoplasia without acromegaly. MEASUREMENTS: Serum IGF-I, IGF-II, IGFBP-2 and IGFBP-3 were measured using specific immunoassays. Tissue expression of IGFBP-2, IGFBP-3 and p53 status were determined by immunohistochemistry. PATIENTS: Group 1: 26 age- and sex-matched control subjects (range 40-69 years); group 2: 18 patients with acromegaly without colonic neoplasia (range 39-68 years); group 3: 18 patients with acromegaly and colonic neoplasia (range 41-74 years, 11 = adenoma, seven = carcinoma); group 4: 19 patients with colonic neoplasia without endocrine disease (range 43-91 years, four = adenoma, 15 = carcinoma). Immunohistochemical staining of colonic biopsies was performed for IGFBP-2, IGFBP-3 and p53 in groups 3 and 4. RESULTS: Mean serum IGF-I and IGFBP-3 levels were significantly elevated in group 2 (371 +/- 131 microg/l and 6.5 +/- 1.8 mg/l, respectively) and group 3 (379 +/- 174 microg/l and 5.8 +/- 1.6 mg/l, respectively), and significantly reduced in group 4 (103 +/- 36 microg/l and 2.4 +/- 1 mg/l) compared to controls (165 +/- 40 microg/l and 4.7 +/- 1 mg/l; P < 0.0001, P < 0.001, respectively). However, median serum IGFBP-2 levels were significantly elevated in group 3 (P < 0.01) and group 4 (P < 0.0001). Immunostaining for IGFBP-2 showed strong areas of immunoreactivity in the cytoplasm of malignant colonic epithelium compared to benign epithelium. IGFBP-3 immunostaining showed strong areas of immunoreactivity in the cytoplasm and in the nucleus of malignant and benign colonic epithelium compared to the normal epithelium. Nuclear staining for p53 was observed in three patients from group 3 (two carcinoma, one adenoma) and four patients from group 4 (all carcinoma). CONCLUSION: Our results describe changes in IGFBP-2 expression in colonic neoplasia in patients with and without acromegaly, which suggest that this binding protein may regulate local bioavailability of IGF, which in turn could modulate colonic cell proliferation and/or differentiation.
spellingShingle Miraki-Moud, F
Jenkins, P
Fairclough, P
Jordan, S
Bustin, SA
Jones, A
Lowe, D
Monson, J
Grossman, AB
Besser, G
Camacho-Hübner, C
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title_full Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title_fullStr Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title_full_unstemmed Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title_short Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
title_sort increased levels of insulin like growth factor binding protein 2 in sera and tumours from patients with colonic neoplasia with and without acromegaly
work_keys_str_mv AT mirakimoudf increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT jenkinsp increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT faircloughp increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT jordans increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT bustinsa increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT jonesa increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT lowed increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT monsonj increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT grossmanab increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT besserg increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly
AT camachohubnerc increasedlevelsofinsulinlikegrowthfactorbindingprotein2inseraandtumoursfrompatientswithcolonicneoplasiawithandwithoutacromegaly